Ensign Peak Advisors, Inc Castle Biosciences Inc Transaction History

Ensign Peak Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $49,522 - $75,504	2,200 Added 247.19%	3,090 $81,000
Q4 2021 Feb 11, 2022	BUY	$39.06 - $67.58 $34,763 - $60,146	890 New	890 $38,000
Q1 2021 May 12, 2021	SELL	$58.92 - $97.33 $736,794 - $1.22 Million	-12,505 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$43.6 - $73.05 $652,692 - $1.09 Million	-14,970 Reduced 54.49%	12,505 $840,000
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $696,653 - $942,211	18,109 Added 193.35%	27,475 $1.41 Million

Q2 2020 Aug 12, 2020	BUY	$27.28 - $43.01 $146,057 - $230,275	5,354 Added 133.45%	9,366 $353,000
Q1 2020 May 11, 2020	SELL	$23.08 - $35.53 $377,104 - $580,524	-16,339 Reduced 80.29%	4,012 $120,000
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $320,324 - $713,099	20,351 New	20,351 $699,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $458M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.